Login / Signup

177 Lu-PSMA-617 Radioligand Treatment in Elderly Patients with Metastatic Castration-resistant Prostate Cancer: Therapeutic Efficacy and Safety Assessment.

Ertan SahinUmut ElbogaUfuk CimenMerve OkuyanYusuf Burak Cayirli
Published in: Current radiopharmaceuticals (2024)
Lu-PSMA-617 treatment was a safe and effective treatment option for properly selected elderly mCRPC patients.
Keyphrases
  • end stage renal disease
  • pet ct
  • chronic kidney disease
  • ejection fraction
  • computed tomography
  • pet imaging
  • prognostic factors
  • combination therapy